TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
UTMD

Utah Medical Products Inc

Healthcare · Medical Instruments & Supplies

74.50$ +0.9% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Utah Medical Products Inc (UTMD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 125 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet UTMD
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
83 77 82 86 91 93 97 97 99 100 105 103 104 110 103 104 107 112 114 117 120 116 120 116 118 124 128 130 131 135 135 130 130 123 123 121 122 123 124 125
42 35 41 44 48 49 53 56 59 61 46 46 50 55 51 53 57 62 67 71 76 73 79 79 84 90 95 99 102 106 107 102 102 96 96 94 97 98 100 101
32 26 31 34 38 40 43 46 49 51 33 33 37 43 40 42 46 52 56 60 64 61 66 66 70 75 81 -0.3 -0.3 93 94 89 88 83 83 82 84 86 87 88
32 26 31 34 38 40 43 46 49 51 33 33 37 43 40 42 46 52 56 60 64 61 66 66 70 75 81 85 88 93 94 89 88 83 83 82 84 86 87 88
5.0 3.2 4.2 4.5 4.7 3.6 4.2 4.5 4.5 4.0 4.9 5.2 5.1 4.7 4.4 3.8 4.3 4.1 4.2 4.6 4.9 5.1 5.7 4.9 6.0 5.5 3.8 3.6 3.5 3.4 3.6 3.7 3.7 4.1 3.9 3.6 3.7 3.5 3.6 3.6
4.5 4.5 4.8 4.8 5.0 5.2 5.6 5.2 4.9 5.4 7.6 7.7 6.7 6.9 6.8 6.6 6.3 6.2 6.0 6.1 6.3 6.6 7.4 7.3 8.3 8.8 9.9 10 9.7 9.6 9.2 9.1 9.1 8.8 8.6 8.2 8.1 7.9 8.7 9.0
7.3 10.0 10 10 10 12 12 11 11 10 10 10 9.8 11 10 10 11 11 11 11 11 11 11 11 10 10 10 11 – – – – – – – – – – – –
14 13 14 14 14 14 14 14 14 14 14 14 13 14 14 14 14 14 14 14 14 14 14 13 13 13 14 14 13 14 14 14 14 14 14 14 14 14 14 14
20 18 18 18 18 18 18 16 16 15 35 33 31 30 28 26 25 24 22 21 19 18 15 13 11 10 8.9 7.5 5.6 4.9 4.4 3.9 3.6 2.9 2.4 2.0 1.4 0.8 0.4 0.3
10 7.3 9.6 8.7 9.5 15 15 14 10 11 13 9.4 9.1 8.7 8.8 8.3 8.7 8.9 9.5 9.4 9.8 8.5 11 8.7 10 9.6 9.8 8.7 7.5 7.1 7.7 6.0 5.5 5.1 5.5 3.3 3.7 3.3 4.0 2.5
5.5 3.0 5.4 4.4 5.2 5.3 5.1 5.2 4.8 5.3 7.0 3.8 3.7 3.4 3.8 3.2 3.6 3.8 4.6 4.4 5.0 3.7 6.1 4.4 6.3 6.0 6.1 5.1 4.2 4.7 5.5 3.9 3.4 3.8 4.3 2.3 3.0 2.6 3.5 2.1
– – – – – – – – – – 0.0 – – – – – – – – 0.0 – 0.1 – – – 0.1 – – – 0.0 – – – 0.1 – – – – – –
0.9 0.9 1.0 1.0 1.1 0.9 1.1 1.0 0.7 1.0 2.8 0.9 0.8 1.1 1.1 0.6 0.7 0.8 0.8 1.2 1.0 0.8 1.5 0.8 1.3 1.2 1.0 1.3 0.5 0.8 1.0 0.8 1.0 0.7 0.9 0.7 0.8 0.9 1.2 0.9
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – 0.4 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
73 69 73 77 81 78 83 83 89 89 92 94 95 101 94 95 98 103 105 107 110 107 109 107 108 114 118 122 124 128 128 124 124 117 117 118 118 119 120 122
79 81 84 87 89 86 89 92 98 100 102 105 107 111 107 107 109 111 113 115 118 115 118 119 123 126 129 132 135 138 139 135 134 129 128 127 128 129 130 132
3.8 3.7 3.7 3.7 3.7 3.7 3.7 3.8 3.8 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.7 3.6 3.6 3.6 3.6 3.6 3.6 3.6 3.5 3.5 3.4 3.3 3.2 3.2 3.2 3.2 3.2

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?